Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8329867 CTLA4-Ig immunoadhesins

Patent 8329867 was granted and assigned to Xencor on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8329867

Patent Inventor Names

Gregory A. Lazar0

Matthew J. Bernett0

Date of Patent

December 11, 2012

Patent Application Number

13032491

Date Filed

February 22, 2011

Patent Citations Received

‌

US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

‌

US Patent 11788085 Treating and preventing microbial infections

‌

US Patent 11851486 Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils

‌

US Patent 11891434 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly

‌

US Patent 12076375 Treating and preventing

‌

US Patent 12116414 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

‌

US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof

Patent Primary Examiner

‌

Ilia Ouspenski

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8329867 CTLA4-Ig immunoadhesins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API